Cumberland Pharmaceuticals Inc. announced that Rick S. Greene, who has been serving as the company's Vice President and Chief Financial Officer (Principal Financial Officer), will transition out of that role effective October 14, 2015, as he pursues interests outside of the Company following his acceptance of an appointment at a privately held biopharmaceutical company. A.J. Kazimi, Chief Executive Officer of the Company, will serve as the Company's Principal Financial Officer in addition to his duties as Principal Executive Officer. Mr. Kazimi will oversee and supervise the activities of the Company's Finance and Accounting Department.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
1.51 USD | +0.67% | -13.22% | -15.72% |
May. 07 | Transcript : Cumberland Pharmaceuticals Inc., Q1 2024 Earnings Call, May 07, 2024 | |
May. 07 | Earnings Flash (CPIX) CUMBERLAND PHARMACEUTICALS Reports Q1 Revenue $8.5M | MT |
1st Jan change | Capi. | |
---|---|---|
-15.72% | 21.26M | |
+21.98% | 43.92B | |
+24.56% | 23.09B | |
+19.25% | 15.35B | |
+14.03% | 13.61B | |
+46.40% | 12.02B | |
-10.14% | 7B | |
-0.05% | 6.79B | |
-8.87% | 5.73B | |
+13.07% | 5.6B |
- Stock Market
- Equities
- CPIX Stock
- News Cumberland Pharmaceuticals Inc.
- Cumberland Pharmaceuticals, Inc. Announces Executive Changes